Daré Bioscience (DARE) Revenue & Revenue Breakdown
Daré Bioscience Revenue Highlights
Latest Revenue (Y)
$9.78M
Latest Revenue (Q)
$25.43K
Main Segment (Y)
License And Collaboration Revenues
Daré Bioscience Revenue by Period
Daré Bioscience Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $9.78M | 248.45% |
| 2023-12-31 | $2.81M | -71.92% |
| 2022-12-31 | $10.00M | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | -100.00% |
| 2016-12-31 | $766.00K | 100.00% |
| 2015-12-31 | - | -100.00% |
| 2014-12-31 | $80.00K | 1233.33% |
| 2013-12-31 | $6.00K | -99.04% |
| 2012-12-31 | $625.00K | 104.92% |
| 2011-12-31 | $305.00K | - |
Daré Bioscience generated $9.78M in revenue during NA 2024, up 248.45% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Daré Bioscience Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $25.43K | -139.95% |
| 2024-12-31 | $-63.65K | -252.66% |
| 2024-09-30 | $41.69K | 85.81% |
| 2024-06-30 | $22.44K | 141.22% |
| 2024-03-31 | $9.30K | -99.49% |
| 2023-12-31 | $1.81M | 80.80% |
| 2023-09-30 | $1.00M | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | -100.00% |
| 2022-12-31 | $10.00B | 100.00% |
| 2022-09-30 | - | -100.00% |
| 2022-06-30 | $10.00M | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | -100.00% |
| 2017-12-31 | $-1.83M | 100.00% |
| 2017-09-30 | - | -100.00% |
| 2017-06-30 | $642.00K | -46.14% |
| 2017-03-31 | $1.19M | 55.61% |
| 2016-12-31 | $766.00K | 100.00% |
| 2016-09-30 | - | 100.00% |
| 2016-06-30 | - | 100.00% |
| 2016-03-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2015-09-30 | - | 100.00% |
| 2015-06-30 | - | 100.00% |
| 2015-03-31 | - | 100.00% |
| 2014-12-31 | - | 100.00% |
| 2014-09-30 | - | -100.00% |
| 2014-06-30 | $33.00K | -29.79% |
| 2014-03-31 | $47.00K | 683.33% |
| 2013-12-31 | $6.00K | 100.00% |
| 2013-09-30 | - | 100.00% |
| 2013-06-30 | - | 100.00% |
| 2013-03-31 | - | - |
Daré Bioscience generated $25.43K in revenue during Q1 2025, up -139.95% compared to the previous quarter, and up 1.41% compared to the same period a year ago.
Daré Bioscience Revenue Breakdown
Daré Bioscience Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 22 | Dec 20 |
|---|---|---|---|
| License And Collaboration Revenues | $11.00M | $10.00M | - |
| Royalty Revenue | $18.00K | - | - |
| Grant | - | - | $2.50M |
Daré Bioscience's latest annual revenue breakdown by segment (product or service), as of Dec 24: License And Collaboration Revenues (99.84%), and Royalty Revenue (0.16%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Sep 24 | Sep 23 | Sep 22 | Jun 22 |
|---|---|---|---|---|---|---|
| License And Collaboration Revenue | $12.80M | $12.80M | $12.80M | - | - | - |
| License And Collaboration Revenues | - | - | - | $11.00M | $10.00M | $10.00M |
Daré Bioscience's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: License And Collaboration Revenue (100.00%).
Daré Bioscience Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Sep 22 | Jun 22 |
|---|---|---|
| License And Collaboration Revenues | $10.00M | $10.00M |
Daré Bioscience's latest quarterly revenue breakdown by geography, as of Sep 22: License And Collaboration Revenues (100.00%).
Daré Bioscience Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| CRIS | Curis | $10.91M | $2.75M |
| DARE | Daré Bioscience | $9.78M | $25.43K |
| PULM | Pulmatrix | $7.81M | - |
| ANL | Adlai Nortye Ltd. American Depositary Shares | $5.00M | $2.50M |
| LEXX | Lexaria Bioscience | $464.28K | $174.00K |
| EDSA | Edesa Biotech | - | - |
| ASBP | Aspire Biopharma | - | - |
| AIMD | Ainos | - | $106.21K |
| NXTC | NextCure | - | - |
| FBLG | FibroBiologics | - | - |